Epicor says loss narrowed in 2nd quarter, adjusted profit meets analyst expectations
By admin
Epicor 2Q loss narrows
IRVINE, Calif. — Business software maker Epicor Software Corp. said Thursday that its second-quarter loss narrowed as revenue climbed.
For the April-June quarter, Epicor’s loss totaled $1 million, or 2 cents per share, compared with a loss of $6.7 million, or 11 cents per share, in the year-ago quarter.
When excluding one-time items, Epicor … Original article on : Epicor says loss narrowed in 2nd quarter, adjusted profit meets analyst expectations.
July 30th, 2010
This author published 8935 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research